Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14849]

AACR: Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

AACR: Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

AACR: First-in-class cancer metabolism drug AG-221 shows clinical activity in advanced blood cancers

AACR: First-in-class cancer metabolism drug AG-221 shows clinical activity in advanced blood cancers

AACR: Study identifies potential predictor of clinical outcome in patients with lung cancer treated with the investigational immunotherapy MK-3475

AACR: Study identifies potential predictor of clinical outcome in patients with lung cancer treated with the...

ESTRO: The prognosis of tumours that are positive for human papilloma virus in head and neck cancers varies according to their site

ESTRO: The prognosis of tumours that are positive for human papilloma virus in head and neck cancers varies...

ESTRO: Helium ions may provide superior, better-targeted treatment in paediatric radiotherapy

ESTRO: Helium ions may provide superior, better-targeted treatment in paediatric radiotherapy

ELCC: PD-L1 expression and association with survival in mesothelioma

ELCC: PD-L1 expression and association with survival in mesothelioma

ELCC: PD-L1 and PD-1 expression in a cohort of molecularly selected NSCLC patients

ELCC: PD-L1 and PD-1 expression in a cohort of molecularly selected NSCLC patients

ELCC: Diagnosis and targeting lung adenocarcinoma with RET fusion

ELCC: Diagnosis and targeting lung adenocarcinoma with RET fusion

ELCC: Phase I study of CO-1686 in patients with EGFR mutated recurrent, advanced NSCLC

ELCC: Phase I study of CO-1686 in patients with EGFR mutated recurrent, advanced NSCLC

ELCC: QoL in ENSURE study of first-Line Erlotinib vs. Gemcitabine/Cisplatin in Asian patients with EGFR mutation-positive NSCLC

ELCC: QoL in ENSURE study of first-Line Erlotinib vs. Gemcitabine/Cisplatin in Asian patients with EGFR mutation...

More from ecancer